Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Network
-
MCG Minority-Based Community Clinical Oncology Program
Jillella, A., Ghamande, S. A., JILLELLA, A. P., JILLELLA, A. P., GHAMANDE, S., KALLAB, A., JILLELLA, A. P. & KALLAB, A. M.
Project: Research project
-
-
GHSU Minority-Based Community Clinical Oncology Program
Ghamande, S. A., Jillella, A., GHAMANDE, S., JILLELLA, A. & KALLAB, A.
Project: Research project
-
-
Pharmacogenetics as a predictor chemotherapy induced peripheral neuropathy in gynecologic cancer patients treated with Taxane-based chemotherapy
Mysona, D., Dorr, K., Ward, A., Shaver, E., Rungruang, B. & Ghamande, S., Jan 2023, In: Gynecologic Oncology. 168, p. 114-118 5 p.Research output: Contribution to journal › Article › peer-review
-
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Mirza, M. R., González-Martín, A., Graybill, W. S., O’Malley, D. M., Gaba, L., Stephanie Yap, O. W., Guerra, E. M., Rose, P. G., Baurain, J. F., Ghamande, S. A., Denys, H., Prendergast, E., Pisano, C., Follana, P., Baumann, K., Calvert, P. M., Korach, J., Li, Y., Malinowska, I. A., Gupta, D., & 1 others , Jun 15 2023, In: Cancer. 129, 12, p. 1846-1855 10 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer
Herzog, T. J., Pignata, S., Ghamande, S. A., Rubio, M. J., Fujiwara, K., Vulsteke, C., Armstrong, D. K., Sehouli, J., Coleman, R. L., Gabra, H., Scambia, G., Monk, B. J., Arranz, J. A., Ushijima, K., Hanna, R., Zamagni, C., Wenham, R. M., González-Martín, A., Slomovitz, B., Jia, Y., & 4 others , Mar 2023, In: Gynecologic Oncology. 170, p. 300-308 9 p.Research output: Contribution to journal › Article › peer-review
-
Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study
Moore, K. N., Chambers, S. K., Hamilton, E. P., Chen, L. M., Oza, A. M., Ghamande, S. A., Konecny, G. E., Plaxe, S. C., Spitz, D. L., Geenen, J. J. J., Troso-Sandoval, T. A., Cragun, J. M., Rodrigo Imedio, E., Kumar, S., Mugundu, G. M., Lai, Z., Chmielecki, J., Jones, S. F., Spigel, D. R. & Cadoo, K. A., Jan 1 2022, In: Clinical Cancer Research. 28, 1, p. 36-44 9 p.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45)
Monk, B. J., Parkinson, C., Lim, M. C., O'malley, D. M., Oaknin, A., Wilson, M. K., Coleman, R. L., Lorusso, D., Bessette, P., Ghamande, S., Christopoulou, A., Provencher, D., Prendergast, E., Demirkiran, F., Mikheeva, O., Yeku, O., Chudecka-Glaz, A., Schenker, M., Littell, R. D., Safra, T., & 19 others , May 1 2022, In: Journal of Clinical Oncology. 381, JCO.22.01003.Research output: Contribution to journal › Article › peer-review
Open Access43 Scopus citations